Core Viewpoint - The company has established an Artificial Intelligence Medical Advisory Committee to provide strategic guidance and expert insights for the development of its AI-driven digital health platform, Lets Go, reflecting its commitment to building a preventive healthcare ecosystem in emerging markets [1] Group 1 - The newly formed advisory committee aims to assist the board in advancing the Lets Go platform, which is part of the company's wholly-owned subsidiary, Hong Kong Fuhe Holdings Limited, and its innovation division, Resohealth FZCO [1] - Lets Go is positioned as Reso Health's flagship AI health platform, designed to offer comprehensive, digitally-driven health management solutions to employers, insurance companies, and healthcare institutions [1] - The platform is based on the preventive healthcare philosophy of the traditional Chinese medicine brand "Ye Kai Tai," which has a history of 400 years, integrating traditional medical wisdom with modern AI technology to provide solutions in the global health sector [1] Group 2 - The company is focusing on key emerging markets, including the UAE, East Africa, India, and Southeast Asia, to implement its preventive healthcare ecosystem [1]